Literature DB >> 14147809

THE ANTI-TUMOR ACTIVITY OF 2-KETO-3-ETHOXYBUTYRALDEHYDE BIS(THIOSEMICARBAZONE) AND RELATED COMPOUNDS.

H G PETERING, H H BUSKIRK, G E UNDERWOOD.   

Abstract

Entities:  

Keywords:  ANTINEOPLASTIC AGENTS; CARCINOMA 256, WALKER; EXPERIMENTAL LAB STUDY; PHARMACOLOGY; RATS; THIOSEMICARBAZONES

Mesh：

Substances：

Year:  1964        PMID： 14147809

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  14 in total

1.  Copper-64-diacetyl-bis(N4-methylthiosemicarbazone): An agent for radiotherapy.

Authors:  J Lewis; R Laforest; T Buettner; S Song; Y Fujibayashi; J Connett; M Welch
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-30       Impact factor: 11.205

2.  Development of a high performance zinc-62/copper-62 radionuclide generator for positron emission tomography.

Authors:  J Zweit; R Goodall; M Cox; J W Babich; G A Potter; H L Sharma; R J Ott
Journal:  Eur J Nucl Med       Date:  1992

3.  Pharmacological activity of metal binding agents that alter copper bioavailability.

Authors:  Marian E Helsel; Katherine J Franz
Journal:  Dalton Trans       Date:  2015-05-21       Impact factor: 4.390

Review 4.  Positron emission tomography to assess hypoxia and perfusion in lung cancer.

Authors:  Eline E Verwer; Ronald Boellaard; Astrid Am van der Veldt
Journal:  World J Clin Oncol       Date:  2014-12-10

Review 5.  Iron-targeting antitumor activity of gallium compounds and novel insights into triapine(®)-metal complexes.

Authors:  Christopher R Chitambar; William E Antholine
Journal:  Antioxid Redox Signal       Date:  2012-10-03       Impact factor: 8.401

6.  Species dependence of [64Cu]Cu-Bis(thiosemicarbazone) radiopharmaceutical binding to serum albumins.

Authors:  Nathan E Basken; Carla J Mathias; Alexander E Lipka; Mark A Green
Journal:  Nucl Med Biol       Date:  2008-01-30       Impact factor: 2.408

7.  Copper-tolfenamic acid: evaluation of stability and anti-cancer activity.

Authors:  Myrna Hurtado; Umesh T Sankpal; Jaya Chhabra; Deondra T Brown; Rajasekhar Maram; Rafid Patel; Raj K Gurung; Jerry Simecka; Alvin A Holder; Riyaz Basha
Journal:  Invest New Drugs       Date:  2018-05-15       Impact factor: 3.850

8.  Changes in regional brain perfusion during functional brain activation: comparison of [(64)Cu]-PTSM with [(14)C]-Iodoantipyrine.

Authors:  D P Holschneider; J Yang; T R Sadler; N B Galifianakis; M H Bozorgzadeh; J R Bading; P S Conti; J-M I Maarek
Journal:  Brain Res       Date:  2008-07-19       Impact factor: 3.252

9.  A New Thiosemicarbazone-Based Fluorescence "Turn-on" Sensor for Zn(2+) Recognition with a Large Stokes Shift and its Application in Live Cell Imaging.

Authors:  Lijun Tang; Zhenlong Huang; Zhuxuan Zheng; Keli Zhong; Yanjiang Bian
Journal:  J Fluoresc       Date:  2016-06-22       Impact factor: 2.217

10.  Clinical application of 62Zn/62Cu positron generator: perfusion and plasma pool images in normal subjects.

Authors:  H Okazawa; Y Fujibayashi; Y Yonekura; N Tamaki; S Nishizawa; Y Magata; K Ishizu; T Tsuchida; N Sadato; J Konishi
Journal:  Ann Nucl Med       Date:  1995-05       Impact factor: 2.668
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.